Literature DB >> 561124

Serum lipoproteins and C567-INH activity.

T F Lint, C L Behrends, H Gewurz.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 561124

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  8 in total

1.  Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3.

Authors:  Marta Biedzka-Sarek; Jari Metso; Andreas Kateifides; Taru Meri; T Sakari Jokiranta; Artur Muszyński; Joanna Radziejewska-Lebrecht; Vassilis Zannis; Mikael Skurnik; Matti Jauhiainen
Journal:  J Biol Chem       Date:  2011-09-06       Impact factor: 5.157

2.  The binding of human low-density lipoproteins to the surface of schistosomula of Schistosoma mansoni is inhibited by polyanions and reduces the binding of anti-schistosomal antibodies.

Authors:  C P Chiang; J P Caulfield
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

Review 3.  Membrane signaling by complement C5b-9, the membrane attack complex.

Authors:  A Nicholson-Weller; J A Halperin
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 4.  Is the membrane attack complex of complement an enzyme?

Authors:  M D Boyle
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

Review 5.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

6.  Effects of zinc chloride on guinea pig complement component activity in vitro: concentration-dependent inhibition and enhancement.

Authors:  D W Montgomery; M Chvapil; C F Zukoski
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.

Authors:  N H Choi-Miura; T Sakamoto; S Ohtaki; H Nakamura; S Ishizawa; Y Takagi; K Gomi; M Tomita
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.

Authors:  S I Rosenfeld; C H Packman; J P Leddy
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.